HOXD9 and breast carcinoma: For De Almeida et al. [9], 3 of 5 CpGs showed evidence of associations with breast cancer-specific survival that were consistent in direction (P ≤ 0.01, HRs per SD between 1.41 and 1.58 for HOXD9, C17orf93 and TDRD10) in Model 0 used by the authors, Table 2.